Clinical practice guidelines for prostate cancer screening (PCS) describe the use and interpretation of prostate-specific antigen (PSA) tests; however, recommendations for PSA screening as part of routine medical care vary. The gene discussed is KLK3; the disease is prostate carcinoma.